← Open Payments lookup

KELLY HAUSENBAUER: Open Payments

NPI 1053695304 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,026 in 125 payments from 19 companies in 2025. Trend: 2023 $816 · 2024 $1,977 · 2025 $3,026

Food & beverage: $2,949Education: $77
CompanyPaymentsAmount
ABBVIE INC.15$413
Janssen Biotech, Inc.10$363
Takeda Pharmaceuticals U.S.A., Inc.13$293
Gilead Sciences, Inc.9$252
Ipsen Biopharmaceuticals, Inc8$214
Madrigal Pharmaceuticals10$196
Phathom Pharmaceuticals, Inc.7$182
Regeneron Healthcare Solutions, Inc.10$166
PFIZER INC.8$162
Ardelyx, Inc.5$158

Products named: TREMFYA, DUPIXENT, ENTYVIO, RINVOQ, IQIRVO, REZDIFFRA, VOQUEZNA, IBSRELA.

Industry payments across MD — which companies pay providers there.